Skip to content
Catalyst

Limnospira platensisFinding

Limnospira platensis decreases interleukin‑6 concentration

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“After normalization with baseline, Figure 4B shows a significant decrease in serum IL-6 level at 1, 3, and 6 months of low- and standard-dose Arthrospira consumption (* p < 0.05, ** p < 0.01, *** p < 0.001, compared to control).”
Quoted verbatim from Arthrospira Enhances Seroclearance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue through Modulation of TNF-α/IFN-γ Profile.
This finding among the 87 findings on its endpoint

Limnospira platensis

Interleukin-6 concentration

lowers

Who
Adults aged 20 to 75 with chronic hepatitis B on nucleos(t)ide analogues for at least one year with undetectable HBV DNA; nucleos(t)ide analogue continued in all arms (background); 60 randomised to control, 3 g/day or 6 g/day Arthrospira, 56 retained; low and standard dose groups reported together against control
Dose studied
3 g daily or 6 g daily as add-on to nucleos(t)ide analogue, 6 months

Moderate evidencePMID 35889747 · 2022

02 · The study

Study
RCT
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M720EKTN5KF1AHEWPXZ7SKMM